122 related articles for article (PubMed ID: 33133277)
1. Screening Strategy Modification Based on Personalized Breast Cancer Risk Stratification and its Implementation in the National Guidelines - Pilot Study.
Krajc M; Gareth Evans D; Blatnik A; Lokar K; Žagar T; Tomšič S; Žgajnar J; Zadnik V
Zdr Varst; 2020 Dec; 59(4):211-218. PubMed ID: 33133277
[TBL] [Abstract][Full Text] [Related]
2. Breast cancer risk assessment and risk distribution in 3,491 Slovenian women invited for screening at the age of 50; a population-based cross-sectional study.
Jarm K; Zadnik V; Birk M; Vrhovec M; Hertl K; Klanecek Z; Studen A; Sval C; Krajc M
Radiol Oncol; 2023 Sep; 57(3):337-347. PubMed ID: 37665745
[TBL] [Abstract][Full Text] [Related]
3. Breast cancer risk prediction using Tyrer-Cuzick algorithm with an 18-SNPs polygenic risk score in a European population with below-average breast cancer incidence.
Oblak T; Škerl P; Narang BJ; Blagus R; Krajc M; Novaković S; Žgajnar J
Breast; 2023 Dec; 72():103590. PubMed ID: 37857130
[TBL] [Abstract][Full Text] [Related]
4. Breast cancer risk based on adapted IBIS prediction model in Slovenian women aged 40-49 years - could it be better?
Oblak T; Zadnik V; Krajc M; Lokar K; Zgajnar J
Radiol Oncol; 2020 Jul; 54(3):335-340. PubMed ID: 32614783
[TBL] [Abstract][Full Text] [Related]
5. Performance of the IBIS/Tyrer-Cuzick model of breast cancer risk by race and ethnicity in the Women's Health Initiative.
Kurian AW; Hughes E; Simmons T; Bernhisel R; Probst B; Meek S; Caswell-Jin JL; John EM; Lanchbury JS; Slavin TP; Wagner S; Gutin A; Rohan TE; Shadyab AH; Manson JE; Lane D; Chlebowski RT; Stefanick ML
Cancer; 2021 Oct; 127(20):3742-3750. PubMed ID: 34228814
[TBL] [Abstract][Full Text] [Related]
6. Estimating the Cost of 3 Risk Prediction Strategies for Potential Use in the United Kingdom National Breast Screening Program.
Wright SJ; Eden M; Ruane H; Byers H; Evans DG; Harvie M; Howell SJ; Howell A; French D; Payne K
MDM Policy Pract; 2023; 8(1):23814683231171363. PubMed ID: 37152662
[TBL] [Abstract][Full Text] [Related]
7. Breast cancer risk assessment across the risk continuum: genetic and nongenetic risk factors contributing to differential model performance.
Quante AS; Whittemore AS; Shriver T; Strauch K; Terry MB
Breast Cancer Res; 2012 Nov; 14(6):R144. PubMed ID: 23127309
[TBL] [Abstract][Full Text] [Related]
8. Practical problems with clinical guidelines for breast cancer prevention based on remaining lifetime risk.
Quante AS; Whittemore AS; Shriver T; Hopper JL; Strauch K; Terry MB
J Natl Cancer Inst; 2015 Jul; 107(7):. PubMed ID: 25956172
[TBL] [Abstract][Full Text] [Related]
9. An integrated breast cancer risk assessment and management model based on fuzzy cognitive maps.
Subramanian J; Karmegam A; Papageorgiou E; Papandrianos N; Vasukie A
Comput Methods Programs Biomed; 2015 Mar; 118(3):280-97. PubMed ID: 25697987
[TBL] [Abstract][Full Text] [Related]
10. The impact of using weight estimated from mammographic images
Nair KP; Harkness EF; Gadde S; Lim YY; Maxwell AJ; Moschidis E; Foden P; Cuzick J; Brentnall A; Evans DG; Howell A; Astley SM
Proc SPIE Int Soc Opt Eng; 2017 Mar; 10134():. PubMed ID: 34925706
[TBL] [Abstract][Full Text] [Related]
11. Integrating Clinical and Polygenic Factors to Predict Breast Cancer Risk in Women Undergoing Genetic Testing.
Hughes E; Tshiaba P; Wagner S; Judkins T; Rosenthal E; Roa B; Gallagher S; Meek S; Dalton K; Hedegard W; Adami CA; Grear DF; Domchek SM; Garber J; Lancaster JM; Weitzel JN; Kurian AW; Lanchbury JS; Gutin A; Robson ME
JCO Precis Oncol; 2021; 5():. PubMed ID: 34036224
[TBL] [Abstract][Full Text] [Related]
12. Performance of the Gail and Tyrer-Cuzick breast cancer risk assessment models in women screened in a primary care setting with the FHS-7 questionnaire.
Vianna FSL; Giacomazzi J; Oliveira Netto CB; Nunes LN; Caleffi M; Ashton-Prolla P; Camey SA
Genet Mol Biol; 2019; 42(1 suppl 1):232-237. PubMed ID: 31170278
[TBL] [Abstract][Full Text] [Related]
13. A Case-Control Study to Add Volumetric or Clinical Mammographic Density into the Tyrer-Cuzick Breast Cancer Risk Model.
Brentnall AR; Cohn WF; Knaus WA; Yaffe MJ; Cuzick J; Harvey JA
J Breast Imaging; 2019 Jun; 1(2):99-106. PubMed ID: 31423486
[TBL] [Abstract][Full Text] [Related]
14. 10-year performance of four models of breast cancer risk: a validation study.
Terry MB; Liao Y; Whittemore AS; Leoce N; Buchsbaum R; Zeinomar N; Dite GS; Chung WK; Knight JA; Southey MC; Milne RL; Goldgar D; Giles GG; McLachlan SA; Friedlander ML; Weideman PC; Glendon G; Nesci S; Andrulis IL; John EM; Phillips KA; Daly MB; Buys SS; Hopper JL; MacInnis RJ
Lancet Oncol; 2019 Apr; 20(4):504-517. PubMed ID: 30799262
[TBL] [Abstract][Full Text] [Related]
15. Validation of the International Breast Cancer Intervention Study (IBIS) model in the High Risk Ontario Breast Screening Program: A retrospective cohort study.
Brooks JD; Mah A; Christensen RAG; Arneja J; Eisen A; Chiarelli AM
Genet Med; 2023 Jun; 25(6):100820. PubMed ID: 36919844
[TBL] [Abstract][Full Text] [Related]
16. Breast cancer pathology and stage are better predicted by risk stratification models that include mammographic density and common genetic variants.
Evans DGR; Harkness EF; Brentnall AR; van Veen EM; Astley SM; Byers H; Sampson S; Southworth J; Stavrinos P; Howell SJ; Maxwell AJ; Howell A; Newman WG; Cuzick J
Breast Cancer Res Treat; 2019 Jul; 176(1):141-148. PubMed ID: 30941651
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the Tyrer-Cuzick (International Breast Cancer Intervention Study) model for breast cancer risk prediction in women with atypical hyperplasia.
Boughey JC; Hartmann LC; Anderson SS; Degnim AC; Vierkant RA; Reynolds CA; Frost MH; Pankratz VS
J Clin Oncol; 2010 Aug; 28(22):3591-6. PubMed ID: 20606088
[TBL] [Abstract][Full Text] [Related]
18. Comparing 5-Year and Lifetime Risks of Breast Cancer using the Prospective Family Study Cohort.
MacInnis RJ; Knight JA; Chung WK; Milne RL; Whittemore AS; Buchsbaum R; Liao Y; Zeinomar N; Dite GS; Southey MC; Goldgar D; Giles GG; Kurian AW; ; Andrulis IL; John EM; Daly MB; Buys SS; Phillips KA; Hopper JL; Terry MB
J Natl Cancer Inst; 2021 Jun; 113(6):785-791. PubMed ID: 33301022
[TBL] [Abstract][Full Text] [Related]
19. Breast cancer risk assessment in a mammography screening program and participation in the IBIS-II chemoprevention trial.
Loehberg CR; Jud SM; Haeberle L; Heusinger K; Dilbat G; Hein A; Rauh C; Dall P; Rix N; Heinrich S; Buchholz S; Lex B; Reichler B; Adamietz B; Schulz-Wendtland R; Beckmann MW; Fasching PA
Breast Cancer Res Treat; 2010 May; 121(1):101-10. PubMed ID: 20306293
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
